|
(P1383) |
MicroRNA-25 at the center stage in the regulation of the cardiac fibroblast cytokine secretome |
| |
|
F. Martino, S. Dangwal, C. Falk, J. Lorenzen, T. Thum (Hannover) |
|
(P1384) |
Cardiac mRNA expression of matrix metalloproteinases and their inhibitors is related to fibrotic remodeling in desmoglein 2-mutant mice |
| |
|
M. Gerçek, S. Kant, R. E. Leube, C. A. Krusche (Aachen) |
|
(P1385) |
The soluble guanylyl cyclase activator ataciguat inhibits cardiac myofibroblast differentiation by targeting mitochondrial superoxide |
| |
|
U. Flierl, P. Galuppo, J. Bauersachs, D. Fraccarollo (Hannover) |
|
(P1386) |
Improved function of Relaxin in fibrotic heart failure |
| |
|
D. Lindner, P. M. Becher, S. Hinrichs, M. Schwarzl, N. Fluschnik, S. Blankenberg, D. Westermann (Hamburg) |
|
(P1387) |
Raf kinase inhibitor protein regulates interstitial and replacement cardiac fibrosis |
| |
|
A. Kazakov, R. Hall, T. Meier, F. Lammert, M. Böhm, U. Laufs (Homburg/Saar) |
|
(P1388) |
The transcription factor GATA6 in cardiac fibroblast plays a protective role during pressure overload |
| |
|
H. Wang, N. Froese, M. Szaroszyk, M. Korf-Klingebiel, C. Zwadlo, S. Batkai, T. Thum, K. C. Wollert, J. Bauersachs, J. Heineke (Hannover) |
|
(P1389) |
Adiponectin attenuates adverse cardiac remodelling following cardiac injury by up-regulating matrix metalloproteinase 9 expression |
| |
|
R. Schur, A. Jenke, A. Grüger, H.-P. Schultheiss, U. Landmesser, C. Skurk (Berlin) |
|
(P1390) |
Translation of anti-fibrotic microRNA strategies into a mouse model of chronic allograft dysfunction |
| |
|
C. Schauerte, J. Lorenzen, M. Mengel, H. Haller, T. Thum (Hannover) |
|
(P1391) |
The deficiency of cardiac Protease-Activated Receptor 2 supports an age dependent fibrosis but protects from fibrosis and heart failure post virus infection |
| |
|
A. Weithäuser, K. Savvatis, M. Witkowski, H.-P. Schultheiss, U. Landmesser, U. Rauch-Kröhnert (Berlin) |
|
(P1392) |
Rho-dependent kinases ROCK1 and ROCK2 and their contribution to the myofibroblast phenotype of cardiac fibroblasts |
| |
|
S. Hartmann, A. Jatho, N. Kittana, M. Tiburcy, W.-H. Zimmermann, S. Lutz (Göttingen) |
|
(P1393) |
Cardiac FGF23 correlates with left ventricular hypertrophy in patients with chronic kidney disease |
| |
|
M. Leifheit-Nestler, R. große Siemer, K. Flasbart, W. H. Ziegler, D. Haffner (Hannover) |
|
(P1394) |
Impact of cardiac fibroblast growth factor 23 expression on myocardial fibrosis in patients with chronic kidney disease |
| |
|
F. Kirchhoff, D. Haffner, M. Leifheit-Nestler (Hannover) |